Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer

Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer

<p>Abstract</p> <p>Background</p> <p>Steroid receptor coactivators (SRCs) may modulate estrogen receptor (ER) activity and the response to endocrine treatment in breast cancer, in part through interaction with growth factor receptor signaling pathways. In the present st...

Full description

Bibliographic Details
Main Authors: Moi Line L, Flågeng Marianne, Gjerde Jennifer, Madsen Andre, Røst Therese, Gudbrandsen Oddrun, Lien Ernst A, Mellgren Gunnar
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Cancer
Subjects:
SRC-1
SRC-2/TIF-2
SRC-3/AIB1
HER
HER-2
Breast cancer
Tamoxifen
Online Access:http://www.biomedcentral.com/1471-2407/12/247

Internet

http://www.biomedcentral.com/1471-2407/12/247

Similar Items